Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. J. Smith is active.

Publication


Featured researches published by J. J. Smith.


European Journal of Cancer | 2014

EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

Cornelis J. H. van de Velde; P.G. Boelens; Josep M. Borràs; Jan Willem Coebergh; A. Cervantes; Lennart Blomqvist; Regina G. H. Beets-Tan; Colette B.M. van den Broek; Gina Brown; Eric Van Cutsem; Eloy Espín; Karin Haustermans; Bengt Glimelius; Lene Hjerrild Iversen; J. Han van Krieken; Corrie A.M. Marijnen; Geoffrey Henning; Jola Gore-Booth; E. Meldolesi; Pawel Mroczkowski; Iris D. Nagtegaal; Peter Naredi; Hector Ortiz; Lars Påhlman; P. Quirke; Claus Rödel; Arnaud Roth; Harm Rutten; Hans J. Schmoll; J. J. Smith

BACKGROUND Care for patients with colon and rectal cancer has improved in the last 20years; however considerable variation still exists in cancer management and outcome between European countries. Large variation is also apparent between national guidelines and patterns of cancer care in Europe. Therefore, EURECCA, which is the acronym of European Registration of Cancer Care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012, the first multidisciplinary consensus conference about cancer of the colon and rectum was held. The expert panel consisted of representatives of European scientific organisations involved in cancer care of patients with colon and rectal cancer and representatives of national colorectal registries. METHODS The expert panel had delegates of the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy & Oncology (ESTRO), European Society of Pathology (ESP), European Society for Medical Oncology (ESMO), European Society of Radiology (ESR), European Society of Coloproctology (ESCP), European CanCer Organisation (ECCO), European Oncology Nursing Society (EONS) and the European Colorectal Cancer Patient Organisation (EuropaColon), as well as delegates from national registries or audits. Consensus was achieved using the Delphi method. For the Delphi process, multidisciplinary experts were invited to comment and vote three web-based online voting rounds and to lecture on the subjects during the meeting (13th-15th December 2012). The sentences in the consensus document were available during the meeting and a televoting round during the conference by all participants was performed. This manuscript covers all sentences of the consensus document with the result of the voting. The consensus document represents sections on diagnostics, pathology, surgery, medical oncology, radiotherapy, and follow-up where applicable for treatment of colon cancer, rectal cancer and metastatic colorectal disease separately. Moreover, evidence based algorithms for diagnostics and treatment were composed which were also submitted to the Delphi process. RESULTS The total number of the voted sentences was 465. All chapters were voted on by at least 75% of the experts. Of the 465 sentences, 84% achieved large consensus, 6% achieved moderate consensus, and 7% resulted in minimum consensus. Only 3% was disagreed by more than 50% of the members. CONCLUSIONS Multidisciplinary consensus on key diagnostic and treatment issues for colon and rectal cancer management using the Delphi method was successful. This consensus document embodies the expertise of professionals from all disciplines involved in the care for patients with colon and rectal cancer. Diagnostic and treatment algorithms were developed to implement the current evidence and to define core treatment guidance for multidisciplinary team management of colon and rectal cancer throughout Europe.


Diseases of The Colon & Rectum | 2006

A National Study on Lymph Node Retrieval in Resectional Surgery for Colorectal Cancer

Paris P. Tekkis; J. J. Smith; Alexander G. Heriot; Ara Darzi; M. R. Thompson; Jeffrey D. Stamatakis; Ireland

PurposeThis study was designed to develop a mathematical model for predicting the number of lymph nodes harvested in bowel cancer resection specimens based on the current clinical practice in the United Kingdom.MethodsProspective clinical data were collected from 8,409 newly diagnosed bowel cancer patients presenting to 79 hospitals in Great Britain and Ireland during a variable 12-month period from 2000 to 2002. A two-level hierarchical regression model was used to identify predictors for lymph node harvest. The model was internally validated by comparing observed and model predicted lymph node harvest for patient subgroups.ResultsInclusion criteria were satisfied by 5,164 patients. The average lymph node harvest was 11.7 nodes with significant between-center variability in lymph node harvest (range, 5.5–21.3 nodes). Increasing age, American Society of Anesthesiology grade, and preoperative radiotherapy were associated with a reduction of lymph node harvest (P < 0.001). Abdominoperineal resection of the rectum and transverse colectomy were the lowest yield procedures for lymph node harvest. Independent predictors of lymph node harvest were age, American Society of Anesthesiology grade, Dukes stage, operative urgency, type of resection, and preoperative radiotherapy. When tested, the model was found to accurately predict lymph node harvest for group statistics (comparison of observed and model predicted lymph node harvest F1,5154 = 0.63; P = 0.427).ConclusionsThe results of the study suggest that the minimum number of lymph nodes harvested in colorectal cancer surgery cannot be set at a fixed value. The lymph node harvest model provides a simple tool to the frontline clinician for comparing standards between multidisciplinary bowel cancer teams.


Colorectal Disease | 2005

Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer

Paris P. Tekkis; Alexander G. Heriot; J. J. Smith; M. R. Thompson; P. J. Finan; Jeffrey D. Stamatakis

Objective  To study circumferential margin involvement (CMI) in patients undergoing restorative, compared with nonrestorative, surgery for rectal cancer.


Diseases of The Colon & Rectum | 2006

Prediction of Postoperative Mortality in Elderly Patients With Colorectal Cancer

Alexander G. Heriot; Paris P. Tekkis; J. J. Smith; C. Richard G. Cohen; Andrew Montgomery; Riccardo A. Audisio; M. R. Thompson; Jeffrey D. Stamatakis

PurposeThis study was designed to develop a model for predicting postoperative mortality in elderly patients undergoing surgery for colorectal cancer.MethodsThis multicenter study was conducted by using routinely collected clinical data, assessing patients older than aged 80 years, with 30-day operative mortality as the primary end point. Data were collected from The Association of Coloproctology of Great Britain and Ireland database, encompassing 8,077 newly diagnosed colorectal cancer patients undergoing resectional surgery in 79 hospitals between April 2000 to March 2002, The Association of Coloproctology Malignant Bowel Obstruction Study, encompassing 1,046 patients with malignant bowel obstruction in 148 hospitals, between April 1998 to March 1999, and The Wales-Trent audit, encompassing 3,522 newly diagnosed colorectal cancer patients, between July 1992 to June 1993. A multilevel logistic regression model was developed to adjust for case-mix and to accommodate the variability of outcomes between the three study populations. The model was internally validated using a Bayesian resampling technique and tested using measures of discrimination, calibration, and subgroup analysis.ResultsA total of 2,533 patients satisfied the inclusion criteria, with a 30-day mortality of 15.6 percent. Multivariate analysis identified the following independent risk factors: age (odds ratio for 85–90, 90–95, >95 vs. 80–85 = 1.1, 1.8, 2.9), American Society of Anesthesiology grade (odds ratio for Grade III, IV vs. I–II = 2.7, 6.1), operative urgency (odds ratio for emergency vs. elective = 1.9), no cancer excision vs. resection (odds ratio = 1.2), and metastatic disease (odds ratio for metastases vs. no metastases = 1.9). The model offered adequate discrimination (area under receiver operator curve = 0.732) and excellent agreement between observed and predicted outcomes during eight colorectal procedures (P = 0.885).ConclusionsThe elderly colorectal cancer model can accurately estimate 30-day mortality in patients older than aged 80 years undergoing surgery for colorectal cancer. Because the mortality can be considerable, this may have important implications when determining management for this group of patients.


Colorectal Disease | 2010

Long-term failure and function after restorative proctocolectomy - a multi-centre study of patients from the UK National Ileal Pouch Registry.

Paris P. Tekkis; Richard E. Lovegrove; Henry S. Tilney; J. J. Smith; P. M. Sagar; Andrew Shorthouse; Neil Mortensen; R. J. Nicholls

Objective  There is little information on the long‐term failure and function after restorative proctocolectomy (RPC). The results of data submitted to a national registry were analysed.


Diseases of The Colon & Rectum | 2005

Management and Outcome of Pouch-Vaginal Fistulas Following Restorative Proctocolectomy

Alexander G. Heriot; Paris P. Tekkis; J. J. Smith; Roberto Bona; Richard Cohen; R. John Nicholls

PURPOSEThe aim of this study was to assess the short-term and long-term outcomes of surgical repair of patients with pouch-vaginal fistulas after restorative proctocolectomy.METHODSA descriptive study was undertaken of all patients developing pouch-vaginal fistulas following restorative proctocolectomy between 1978 and 2003 in a single tertiary referral institution. Kaplan-Meier survival analysis was used to evaluate the time to first pouch-vaginal fistula recurrence and pouch-vaginal fistula–free survival at last follow-up.RESULTSSixty-eight patients (mean age, 32.2 years; standard deviation, 10.7) were identified with a median follow-up of 5.5 (range, 0.2–25.5) years. The origin of the pouch-vaginal fistulas was the pouch-anal anastomosis in 52 (76.5 percent) patients, pouch body/top in 9 (13.2 percent), or cryptoglandular or other source in 7 (10.3 percent). Associated early complications in patients with pouch-vaginal fistulas included pelvic sepsis in 20 (29 percent) patients, anastomotic separation in 6 (24 percent), anastomotic stricture in 16 (24 percent), small bowel obstruction in 17 (25 percent), hemorrhage in 2 (3 percent), or pouchitis in 12 (18 percent). Surgery was undertaken in 59 (87 percent) patients with 14 (20.6 percent) of them undergoing pouch excision/diversion or seton drainage. Forty-five (66 percent) patients underwent primary repair. First recurrence of pouch-vaginal fistula occurred in 27 of 45 (60 percent) patients with a median pouch-vaginal fistula–free interval of 1.6 years (95 percent confidence interval, 0.6–2.7). Fourteen (51.9 percent) patients with recurrent pouch-vaginal fistulas healed following one or more repeat procedures. The diagnosis of Crohn’s disease was made in eight (12 percent) patients, with pouch-vaginal fistulas persisting or recurring in all patients with Crohn’s disease within five years of the primary treatment. Median pouch-vaginal fistula–free survival was 1.4 years for patients with Crohn’s disease and 8.1 years for patients with ulcerative colitis or familial adenomatous polyposis. The pouch-vaginal fistula–free survival improved with repeated local or abdominal repairs for patients with ulcerative colitis. The overall pouch failure rate for patients with pouch-vaginal fistulas was 35 percent (median pouch survival, 4.2 years).CONCLUSIONSPouch-vaginal fistulas can persist and recur indefinitely, even after repeated repairs. Repair in those patients with Crohn’s disease uniformly failed within five years from primary repair. Patients with recurrent pouch-vaginal fistulas and ulcerative colitis should be offered salvage surgery because successful closure following initial failure occurs in approximately 50 percent.


Colorectal Disease | 2005

Long‐term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis

P. P. Tekkis; A. G. Heriot; O. Smith; J. J. Smith; A. C. J. Windsor; R. J. Nicholls

Introduction  The present study aims to evaluate the short‐term and long‐term outcomes of patients undergoing restorative proctocolectomy (RPC) for Crohns disease (CD) and Indeterminate colitis (IC) and to identify factors associated with adverse outcomes.


European Journal of Cancer | 2013

EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe

Cornelis J. H. van de Velde; Cynthia Aristei; P.G. Boelens; Regina G. H. Beets-Tan; Lennart Blomqvist; Josep M. Borràs; Colette B.M. van den Broek; Gina Brown; Jan Willem Coebergh; Eric Van Cutsem; Eloy Espín; Jola Gore-Booth; Bengt Glimelius; Karin Haustermans; Geoffrey Henning; Lene Hjerrild Iversen; J. Han van Krieken; Corrie A.M. Marijnen; Pawel Mroczkowski; Iris D. Nagtegaal; Peter Naredi; Hector Ortiz; Lars Påhlman; P. Quirke; Claus Rödel; Arnaud Roth; Harm Rutten; Hans J. Schmoll; J. J. Smith; P. J. Tanis

BACKGROUND Care for patients with colon and rectal cancer has improved in the last twenty years however still considerable variation exists in cancer management and outcome between European countries. Therefore, EURECCA, which is the acronym of European Registration of cancer care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012 the first multidisciplinary consensus conference about colon and rectum was held looking for multidisciplinary consensus. The expert panel consisted of representatives of European scientific organisations involved in cancer care of patients with colon and rectal cancer and representatives of national colorectal registries. METHODS The expert panel had delegates of the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy & Oncology (ESTRO), European Society of Pathology (ESP), European Society for Medical Oncology (ESMO), European Society of Radiology (ESR), European Society of Coloproctology (ESCP), European CanCer Organisation (ECCO), European Oncology Nursing Society (EONS) and the European Colorectal Cancer Patient Organisation (EuropaColon), as well as delegates from national registries or audits. Experts commented and voted on the two web-based online voting rounds before the meeting (between 4th and 25th October and between the 20th November and 3rd December 2012) as well as one online round after the meeting (4th-20th March 2013) and were invited to lecture on the subjects during the meeting (13th-15th December 2012). The sentences in the consensus document were available during the meeting and a televoting round during the conference by all participants was performed. All sentences that were voted on are available on the EURECCA website www.canceraudit.eu. The consensus document was divided in sections describing evidence based algorithms of diagnostics, pathology, surgery, medical oncology, radiotherapy, and follow-up where applicable for treatment of colon cancer, rectal cancer and stage IV separately. Consensus was achieved using the Delphi method. RESULTS The total number of the voted sentences was 465. All chapters were voted on by at least 75% of the experts. Of the 465 sentences, 84% achieved large consensus, 6% achieved moderate consensus, and 7% resulted in minimum consensus. Only 3% was disagreed by more than 50% of the members. CONCLUSIONS It is feasible to achieve European Consensus on key diagnostic and treatment issues using the Delphi method. This consensus embodies the expertise of professionals from all disciplines involved in the care for patients with colon and rectal cancer. Diagnostic and treatment algorithms were developed to implement the current evidence and to define core treatment guidance for multidisciplinary team management of colon and rectal cancer throughout Europe.


British Journal of Surgery | 2006

Long‐term results of abdominal salvage surgery following restorative proctocolectomy

Paris P. Tekkis; Alexander G. Heriot; J. J. Smith; P. Das; A. Canero; R. J. Nicholls

This study evaluated outcomes of patients who underwent abdominal salvage ileal pouch redo surgery and identified factors associated with pouch failure following restorative proctocolectomy.


Ejso | 2014

Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: Science, opinions and experiences from the experts of surgery

C.J.H. van de Velde; P.G. Boelens; P. J. Tanis; Eloy Espín; Pawel Mroczkowski; Peter Naredi; Lars Påhlman; Hector Ortiz; H.J.T. Rutten; A.J. Breugom; J. J. Smith; A. Wibe; T. Wiggers; Vincenzo Valentini

The first multidisciplinary consensus conference on colon and rectal cancer was held in December 2012, achieving a majority of consensus for diagnostic and treatment decisions using the Delphi Method. This article will give a critical appraisal of the topics discussed during the meeting and in the consensus document by well-known leaders in surgery that were involved in this multidisciplinary consensus process. Scientific evidence, experience and opinions are collected to support multidisciplinary teams (MDT) with arguments for medical decision-making in diagnosis, staging and treatment strategies for patients with colon or rectal cancer. Surgery is the cornerstone of curative treatment for colon and rectal cancer. Standardizing treatment is an effective instrument to improve outcome of multidisciplinary cancer care for patients with colon and rectal cancer. In this article, a review of the following focuses; Perioperative care, age and colorectal surgery, obstructive colorectal cancer, stenting, surgical anatomical considerations, total mesorectal excision (TME) surgery and training, surgical considerations for locally advanced rectal cancer (LARC) and local recurrent rectal cancer (LRRC), surgery in stage IV colorectal cancer, definitions of quality of surgery, transanal endoscopic microsurgery (TEM), laparoscopic colon and rectal surgery, preoperative radiotherapy and chemoradiotherapy, and how about functional outcome after surgery?

Collaboration


Dive into the J. J. Smith's collaboration.

Top Co-Authors

Avatar

Paris P. Tekkis

The Royal Marsden NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

M. R. Thompson

Queen Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexander G. Heriot

Peter MacCallum Cancer Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pawel Mroczkowski

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eloy Espín

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Peter Naredi

Sahlgrenska University Hospital

View shared research outputs
Top Co-Authors

Avatar

C.J.H. van de Velde

Leiden University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge